2xN β Full Portfolio
5 tracked investments Β· listed companies and verified rows first
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesLongitude CapitalOrbiMed+4 more
Kvantify develops software that runs on both quantum computers and classical computing architectures (CPU/GPU) to solve chemistry and biology problems for molecular and drug discovery.
BiotechDeep TechQuantum Computing
Co-investorsQAI VenturesBioCapitalDelphinus Venture CapitalDreamcraftEuropean Innovation Council Fund
Oxford Ionics develops trapped-ion quantum computers using proprietary Electronic Qubit Control technology, designed for businesses to deploy quantum computing applications.
Deep TechHardwareQuantum Computing
Co-investorsOxford Science EnterprisesOxford University InnovationLansdowne PartnersProsus Ventures
Platform for high-throughput material property simulation based on quantum mechanics.
Cambridge, US
Toru Shiozaki(CEO and Co-Founder)
BoardGuanhua Chen(Director)Garnet Chan(Chief Visionary Advisor and Co-founder)
Co-investorsAbies VenturesKyoto University Innovation CapitalUTokyo Innovation Platform Co. Ltd.Embark Ventures
Sparrow Quantum develops quantum computing technology, building on research from the Niels Bohr Institute in Copenhagen where the company originated.
Deep TechHardwareQuantum ComputingCopenhagen, DK
Co-investorsLIFTTScale CapitalEuropean Investment BankNovo Holdings
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.